TIDMETX

RNS Number : 2414G

e-Therapeutics plc

25 May 2017

E-THERAPEUTICS PLC

("e-Therapeutics" or the "Company")

NOTIFICATION BY DIRECTOR

Oxford, UK, 25 May 2017 - e-Therapeutics plc (AIM: ETX), the drug discovery company, announces that it was informed on 25 May 2017 by the Company's Chairman, Mr Iain Ross, that on the afternoon of 24 May 2017, Redx Pharma plc ("Redx"), the drug discovery and development company, announced that it had gone into administration.

Redx's shares were suspended from trading on AIM as at 4.35pm yesterday afternoon. Mr Ross was appointed Chairman of Redx on 1 May 2017.

This announcement is being made pursuant to the requirements of AIM Rule 17 and Schedule 2(g)(v) to the AIM Rules for Companies.

For further information, please contact:

Contacts:

 
  e-Therapeutics plc          Tel: +44 (0) 1993 
   Ray Barlow, CEO             883 125 
   Steve Medlicott, Finance    www.etherapeutics.co.uk 
   Director 
  Numis Securities Limited    Tel: +44 (0) 207 
   Michael Meade / Freddie     260 1000 
   Barnfield                   www.numis.com 
   (Corporate Finance) 
   James Black (Corporate 
   Broking) 
  Instinctif Partners         Tel: +44 (0) 207 
   Melanie Toyne-Sewell /      457 2020 
   Alex Shaw                   Email: e-therapeutics@instinctif.com

About e-Therapeutics plc

e-Therapeutics is a drug discovery company with a unique and proprietary in silico discovery platform. The Company is applying its computational platform to the discovery of new drug candidates for which it can secure robust intellectual property rights.

The therapeutic focus of the Company's discovery activity is in areas of complex disease with unmet medical need, including immuno-oncology. The business model is to partner these preclinical drug candidates.

e-Therapeutics is headquartered in Oxford. For more information about the Company please visit www.etherapeutics.co.uk.

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAOKPDDKBKDAPB

(END) Dow Jones Newswires

May 25, 2017 06:20 ET (10:20 GMT)

E-therapeutics (LSE:ETX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more E-therapeutics Charts.
E-therapeutics (LSE:ETX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more E-therapeutics Charts.